Fact CheckerSign in

NCT06778746Recruiting

Use of Biologics for Severe Asthma in Hong Kong

Source: ClinicalTrials.gov · Last updated 19 Mar 2026

Brief summary (registry, in English)

The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.

Status (registry)
Recruiting
Study type
Observational
Enrollment
360 (estimated)
First submitted
26 Dec 2024
Start date
26 Dec 2024
Primary completion date
26 Dec 2026
Lead sponsor
Chinese University of Hong Kong
Diseases
Asthma
NCT number
NCT06778746

What you commit to

  • Study type: Observational
  • Planned participants: 360
  • From 26 Dec 2024 to the primary completion date, 26 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Patients with respiratory diseases with other known significant respiratory diseases, including tuberculosis (TB)-destroyed lung parenchyma, history of lung resection and lung cancer

Who the study is looking for

  • Patients aged 18 years or older.
  • Patients diagnosed with severe asthma per the Global Initiative for Asthma (GINA) guidelines.
  • Patients who have received biologic therapy for treatment of asthma (including those who received just one dose to allow assessment of the reason for withdrawal)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, NT, HK
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.